1. Home
  2. CSW vs EWTX Comparison

CSW vs EWTX Comparison

Compare CSW & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSW Industrials Inc.

CSW

CSW Industrials Inc.

HOLD

Current Price

$295.48

Market Cap

5.2B

Sector

Industrials

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$39.39

Market Cap

4.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSW
EWTX
Founded
2014
2017
Country
United States
United States
Employees
N/A
127
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.3B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CSW
EWTX
Price
$295.48
$39.39
Analyst Decision
Buy
Buy
Analyst Count
7
14
Target Price
★ $351.86
$52.62
AVG Volume (30 Days)
89.8K
★ 1.3M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 0.41%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 3.04
N/A
Revenue
★ $1,082,549,000.00
N/A
Revenue This Year
$18.51
N/A
Revenue Next Year
$4.26
N/A
P/E Ratio
$97.07
★ N/A
Revenue Growth
★ 23.25
N/A
52 Week Low
$236.66
$15.23
52 Week High
$355.48
$48.51

Technical Indicators

Market Signals
Indicator
CSW
EWTX
Relative Strength Index (RSI) 49.32 46.70
Support Level $282.14 $37.33
Resistance Level $293.90 $41.22
Average True Range (ATR) 8.19 1.74
MACD 0.99 0.25
Stochastic Oscillator 52.06 65.99

Price Performance

Historical Comparison
CSW
EWTX

About CSW CSW Industrials Inc.

CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms & domain expertise across three segments: Contractor Solutions, Engineered Building Solutions, & Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient & performance-enhancing products for residential & commercial HVAC/R & plumbing applications, which are designed for professional end-use customers. The majority of the company's revenue is generated from the Contractor Solutions segment in the U.S. markets. products include mechanical products for heating, ventilation, air conditioning, & refrigeration, plumbing products, grilles, registers, & diffusers, building safety solutions, & high-performance specialty lubricants & sealants.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: